Examination of genera of the Pseudoascoboleae (Ascomycetes, Discomycetes, Ascobolaceae) revealed that many were polytypic. Characters presently used to distinguish these genera are considered to be artificial and true relationships cut across accepted generic lines. Of the genera treated, Thecotheus and parts of Ascophanus, since their asci blue in iodine and their spores bear callose‐pectic markings, are considered more closely related to the Pezizeae. Other genera are excluded from the Pseudoascoboleae because of other striking characters. Since the Pseudoascoboleae is shown to be an artificial grouping, it is proposed to abandon the name, using instead the tribe name Theleboleae, placed in the Pezizaceae rather than the Ascobolaceae, for all of those genera with asci that do not blue in iodine, with smooth, elliptical spores without oil guttules, and with eight‐spored and multispored species. Four new genera are described: Iodophanus, for species of Ascophanus with iodine‐positive asci; Coprotus, for segments of Ascophanus and Ryparobius; Caccobius, for species intermediate to Ascozonus and Thelebolus; and Trichobolus, for the setose members of Thelebolus. The species of Ryparobius not belonging to Coprotus are transferred to Thelebolus.
JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range of content in a trusted digital archive. We use information technology and tools to increase productivity and facilitate new forms of scholarship. For more information about JSTOR, please contact support@jstor.org.. Mycological Society of America is collaborating with JSTOR to digitize, preserve and extend access to Mycologia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.